BUGGIANI, GIONATA
 Distribuzione geografica
Continente #
NA - Nord America 1.814
EU - Europa 739
AS - Asia 523
SA - Sud America 53
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 3.169
Nazione #
US - Stati Uniti d'America 1.787
RU - Federazione Russa 262
IT - Italia 189
SG - Singapore 159
CN - Cina 119
SE - Svezia 99
HK - Hong Kong 62
IE - Irlanda 55
VN - Vietnam 50
BR - Brasile 42
DE - Germania 40
KR - Corea 30
FI - Finlandia 28
BD - Bangladesh 25
FR - Francia 20
JO - Giordania 20
GB - Regno Unito 19
CA - Canada 18
TR - Turchia 16
IN - India 13
JP - Giappone 12
BE - Belgio 10
AU - Australia 9
IQ - Iraq 6
JM - Giamaica 5
UA - Ucraina 5
KE - Kenya 4
CI - Costa d'Avorio 3
MX - Messico 3
NG - Nigeria 3
PK - Pakistan 3
AR - Argentina 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
NL - Olanda 2
PL - Polonia 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
AT - Austria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
ID - Indonesia 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.157
Città #
Santa Clara 264
Ashburn 197
Fairfield 183
Chandler 127
Singapore 100
Woodbridge 95
San Jose 83
Los Angeles 70
Seattle 70
Cambridge 65
Houston 64
Ann Arbor 61
Wilmington 57
Dublin 55
Buffalo 48
Hong Kong 47
Beijing 37
Council Bluffs 34
Rome 31
Altamura 29
Seoul 29
Milan 26
Lawrence 22
Ho Chi Minh City 20
Jacksonville 17
Munich 17
Phoenix 15
Boardman 14
Izmir 14
Princeton 14
Boston 13
Florence 13
Turku 13
Tokyo 12
Lauterbourg 11
San Diego 11
Brussels 10
Melbourne 8
São Paulo 8
The Dalles 8
Hanoi 7
New York 7
Shanghai 7
Dallas 6
Naples 6
Da Nang 5
Medford 5
Moscow 5
Mumbai 5
Paris 5
Hefei 4
Hillsboro 4
Montreal 4
Norwalk 4
Orem 4
Palermo 4
Scandicci 4
Shenzhen 4
Turin 4
Venice 4
Bengaluru 3
Catania 3
Chicago 3
Figino 3
Genoa 3
Kent 3
Kingston 3
Nairobi 3
San Francisco 3
Tappahannock 3
Toronto 3
Abidjan 2
Abuja 2
Amman 2
Atlanta 2
Baghdad 2
Brescia 2
Bắc Giang 2
Cento 2
Chennai 2
Cleveland 2
Denver 2
Düsseldorf 2
Edmonton 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Johannesburg 2
Louisville 2
Madrid 2
Modena 2
North Charleston 2
Ottawa 2
Pune 2
Santa Luzia 2
Tashkent 2
Tianjin 2
Washington 2
Yubileyny 2
Abū Kabīr 1
Totale 2.200
Nome #
Prurigo nodularis and lichen simplex chronicus. 238
New and experimental treatments of vitiligo and other hypomelanoses. 238
Atopic dermatitis. 235
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 235
Efalizumab in the treatment of psoriasis: when comorbidity is an issue. 232
Therapy of environmental mycobacterial infections. 231
A rational approach to the treatment of vitiligo and other hypomelanoses. 220
Photodynamic therapy: treatment of choice for actinic cheilitis? 216
Focused UV-B narrowband microphototherapy (Biopsorin). A new treatment for plaque psoriasis. 199
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 187
Therapeutical approaches in melasma. 183
Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. 170
Paraneoplastic vasculitis and paraneoplastic vascular syndromes 162
Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients. 136
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 63
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 44
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 31
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 31
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis) 31
Risankizumab in very elderly patients in real-world practice 27
Apremilast in Patients Difficult to Treat: A Multicentric Real‐Life Long‐Term Experience 22
Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail 21
Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities 17
Totale 3.169
Categoria #
all - tutte 8.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 0 19 5 2 3 11 10 5 3 34 24
2022/2023389 31 91 18 54 24 58 34 16 47 1 12 3
2023/202478 1 13 14 5 4 6 2 22 2 2 4 3
2024/2025688 10 82 42 104 225 94 6 14 36 14 36 25
2025/20261.009 95 92 101 21 88 24 98 41 133 100 77 139
2026/2027126 28 35 63 0 0 0 0 0 0 0 0 0
Totale 3.169